BALAMINES

Balaji Amines Share Price

₹2,031.65 +34.75 (1.74%)

15 Nov, 2024 21:32

SIP TrendupStart SIP in BALAMINES

Start SIP

Performance

  • Low
  • ₹1,990
  • High
  • ₹2,057
  • 52 Week Low
  • ₹1,960
  • 52 Week High
  • ₹2,735
  • Open Price₹1,997
  • Previous Close₹1,997
  • Volume38,886

Investment Returns

  • Over 1 Month -8.5%
  • Over 3 Month -4.11%
  • Over 6 Month -5.79%
  • Over 1 Year -0%
SIP Lightning

Smart Investing Starts Here Start SIP with Balaji Amines for Steady Growth!

Invest Now

Balaji Amines Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 32.6
  • PEG Ratio
  • 14.9
  • Market Cap Cr
  • 6,583
  • P/B Ratio
  • 3.5
  • Average True Range
  • 61.16
  • EPS
  • 60.31
  • Dividend Yield
  • 0.5
  • MACD Signal
  • -38.37
  • RSI
  • 38.11
  • MFI
  • 41.23

Balaji Amines Financials

Balaji Amines Technicals

EMA & SMA

Current Price
₹2,031.65
+ 34.75 (1.74%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 16
  • 20 Day
  • ₹2,096.75
  • 50 Day
  • ₹2,159.42
  • 100 Day
  • ₹2,199.20
  • 200 Day
  • ₹2,228.70

Resistance and Support

2026.18 Pivot Speed
  • R3 2,128.82
  • R2 2,092.78
  • R1 2,062.22
  • S1 1,995.62
  • S2 1,959.58
  • S3 1,929.02

What's your outlook on Balaji Amines?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Balaji Amines Ltd., is a leading ISO 9001:2015 certified manufacturer of Methylamines, Ethylamines, Specialty Chemicals, and Pharma Excipients. The company is renowned for its advanced manufacturing and R&D capabilities.

Balaji Amines Limited has an operating revenue of Rs. 1,562.59 Cr. on a trailing 12-month basis. An annual revenue de-growth of -30% needs improvement, Pre-tax margin of 18% is great, ROE of 11% is good. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. It is currently FORMING a base in its weekly chart and is trading around 25% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 57 which is a POOR score indicating inconsistency in earnings, a RS Rating of 29 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 73 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Balaji Amines Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Quarterly Results
2024-08-07 Quarterly Results
2024-05-08 Audited Results & Final Dividend
2024-01-31 Quarterly Results
2023-11-08 Quarterly Results

Balaji Amines F&O

Balaji Amines Shareholding Pattern

53.7%
0.14%
1.52%
5.27%
0%
34.07%
5.3%

About Balaji Amines

  • NSE Symbol
  • BALAMINES
  • BSE Symbol
  • 530999
  • Managing Director
  • Mr. D Ram Reddy
  • ISIN
  • INE050E01027

Similar Stocks to Balaji Amines

Balaji Amines FAQs

Balaji Amines share price is ₹2,031 As on 15 November, 2024 | 21:18

The Market Cap of Balaji Amines is ₹6582.7 Cr As on 15 November, 2024 | 21:18

The P/E ratio of Balaji Amines is 32.6 As on 15 November, 2024 | 21:18

The PB ratio of Balaji Amines is 3.5 As on 15 November, 2024 | 21:18

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23